Reading Your Immunology and Genetic Reports for AGM10

Navigating immunology and genetic reports can feel like reading a foreign language. However, for Agammaglobulinemia Type 10 (AGM10), these reports contain the specific “fingerprints” of the disease that help your doctor distinguish it from other immune conditions.

The Immunology Report: Tracking Your “Soldier” Cells

When you look at your immunology lab results, you are primarily looking for two things: the absolute count of your immune cells and the pre-treatment level of immunoglobulins (antibodies) circulating in your blood. (Note: Reference intervals are age- and laboratory-specific; interpret these with your immunologist rather than using one value as a diagnosis.)

1. B-Cell Lymphopenia

The hallmark of AGM10 is the near-total absence of B cells ^[1]. In your report, look for markers labeled CD19+ or CD20+. These are the unique “ID tags” that flow cytometry (a specialized laser-based blood test) uses to count B cells ^[2][3].

• What to expect: In many reported AGM10 cases, the absolute B-cell count is close to zero (e.g., 1 cell per microliter), or the percentage of B cells is less than 0.1% of your total lymphocytes ^[2][1].

2. Dendritic Cell Deficiency

Unlike many other antibody deficiencies, AGM10 often affects dendritic cells, the “scouts” of the immune system ^[4]. Your report may list subsets like cDC1, cDC2, or pDCs ^[5]. In AGM10, these counts are typically lower than normal ^[6][4]. Note that dendritic-cell testing is a highly specialized assay and is not necessarily part of routine clinical monitoring everywhere.

3. Hypogammaglobulinemia

This term simply means low levels of antibodies in the blood. Your report should list three main types:

• IgG: Usually profoundly low prior to treatment (e.g., below 4.0 g/L in an untreated teenager/adult, though this varies by age) ^[2]. Note that once you start Immunoglobulin Replacement Therapy (IgRT), your measured IgG will reflect the donor antibodies infused into your body, not what your body produces.
• IgA and IgM: Often undetectable or extremely low ^[2][1].

The Genetic Report: Decoding the SPI1 Mutation

The genetic report is the “source code” for your diagnosis. It will describe a change in your SPI1 gene, which is responsible for making the PU.1 protein.

Understanding Variant Classifications

Laboratories use a standard system to rank how “sure” they are that a genetic change is causing a disease:

• Pathogenic / Likely Pathogenic: The lab is confident that this specific mutation breaks the PU.1 protein and is the cause of your symptoms ^[7].
• Variant of Uncertain Significance (VUS): This means the lab found a change in your SPI1 gene, but they don’t have enough scientific data yet to prove it causes disease ^[8]. Many AGM10 cases start as a VUS because the disease is so rare ^[2].

Why a VUS Requires More Work

A VUS should not be used alone to formally diagnose AGM10, guide irreversible treatment, or make predictive decisions in relatives. If your report says “VUS,” your doctor may need “tie-breaker” evidence:

• Segregation Testing: Testing your parents. If a parent has the same mutation but is perfectly healthy, it might be a harmless variant—though in AGM10, some healthy people can still carry the gene due to “incomplete penetrance.” Thus, a healthy parent does not automatically prove it harmless, nor does it prove it is disease-causing ^[4][6].
• Functional Studies: Specialized labs can check if your cells actually make the PU.1 protein, though these may be unavailable or inconclusive ^[1][6].
  Review by a clinical geneticist or genetic counselor is highly recommended.

Report Completeness Checklist

Ensure your medical records include these specific items for a thorough AGM10 evaluation:

1. Quantitative Immunoglobulins: Absolute levels of IgG, IgA, and IgM (ideally drawn before treatment starts) ^[9].
2. Lymphocyte Subsets: Absolute counts for T cells (CD3+), B cells (CD19+), and NK cells (CD16/56+) ^[9][10].
3. Dendritic Cell Panel: Specifically looking for myeloid and plasmacytoid dendritic cell counts (ask if this will change your management) ^[6][5].
4. Genetic Detail: The specific “address” of the mutation (e.g., SPI1 c.130G>T) and whether it was “de novo” (a new mutation) or inherited ^[11][2].

If any of these pieces are missing, your immunology team may need to order more specific testing to get the full picture of how AGM10 is affecting your body.